Sun Pharmaceutical Industries Limited (NSEI:SUNPHARMA) agreed to acquire 16.33% stake in Surgimatix, Inc for $3.1 million on February 20, 2024. The transaction is expected to complete by the end of February 2024 and is subject fulfilment of certain conditions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,525 INR | +1.23% | +0.92% | +21.09% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.09% | 43.27B | |
+25.28% | 22.92B | |
+19.22% | 15.43B | |
+13.51% | 12.95B | |
+44.01% | 11.83B | |
-7.79% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.02% | 5.55B | |
+9.14% | 4.9B |
- Stock Market
- Equities
- SUNPHARMA Stock
- News Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Limited agreed to acquire 16.33% stake in Surgimatix, Inc for $3.1 million.